Suchergebnisse - "9NDF7JZ4M3"

PubPharm (4.971)

31

Clot time ratio (CTR) and treatment outcomes in Apixaban-treated atrial fibrillation patients

enthalten in: Scientific reports | 2024

von Onelöv, L. | Božič-Mijovski, M. | Mavri, A.

32

Drug-Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants

enthalten in: Seminars in thrombosis and hemostasis | 2024

von Hellfritzsch, M. | Henriksen, J. | Holt, M. | +1

33

Crushing tablets or sprinkling capsules : Implications for clinical strategy and study performance based on BE studies of rivaroxaban and deferasirox

enthalten in: Clinical and translational science | 2024

von Sus, J. | Bosak, J. | Hauser, T.

34

Andexanet Alfa : What We Have Learned from Clinical Trials and Real-World Data

enthalten in: CNS drugs | 2024

von Frol, S. | Oblak, J. | Šabovič, M. | +1

35

Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy

enthalten in: Clinical pharmacokinetics | 2024

von Ma, Y. | Song, Z. | Li, X. | +3

36

Anticoagulation in atrial fibrillation. A large real-world update

enthalten in: European journal of internal medicine | 2024

von Bo, M. | Fumagalli, S. | Degli Esposti, L. | +12

37

Thrombin as target for prevention of recurrent events after acute coronary syndromes

enthalten in: Thrombosis research | 2024

von Bahit, M. | Gibson, C.

38

Comparison of High- and Low-Dose Rivaroxaban Regimens in Elderly East Asian Patients With Atrial Fibrillation

enthalten in: Journal of Korean medical science | 2024

von Kim, J. | Kim, J. | Park, S. | +9

39

Risk of Major Bleeding Associated with Concomitant Direct-Acting Oral Anticoagulant and Clopidogrel Use : A Retrospective Cohort Study

enthalten in: Drug safety | 2024

von Hwang, Y. | Chang, H. | Metkus, T. | +4

40

Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis

enthalten in: The European journal of health economics : HEPAC : health economics in prevention and care | 2024

von Situ, M. | Schwarz, U. | Zou, G. | +4